Cited by 370Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic ControlPsychosomatic Disorders and Their Treatments

Postural tachycardia syndrome: a heterogeneous and multifactorial disorder

Open access
Benarroch, Eduardo E.·2012·Mayo Clinic Proceedings

Abstract

Postural tachycardia syndrome (POTS) is defined by a heart rate increment of 30 beats/min or more within 10 minutes of standing or head-up tilt in the absence of orthostatic hypotension; the standing heart rate is often 120 beats/min or higher. POTS manifests with symptoms of cerebral hypoperfusion and excessive sympathoexcitation. The pathophysiology of POTS is heterogeneous and includes impaired sympathetically mediated vasoconstriction, excessive sympathetic drive, volume dysregulation, and deconditioning. POTS is frequently included in the differential diagnosis of chronic unexplained symptoms, such as inappropriate sinus tachycardia, chronic fatigue, chronic dizziness, or unexplained spells in otherwise healthy young individuals. Many patients with POTS also report symptoms not attributable to orthostatic intolerance, including those of functional gastrointestinal or bladder disorders, chronic headache, fibromyalgia, and sleep disturbances. In many of these cases, cognitive and behavioral factors, somatic hypervigilance associated with anxiety, depression, and behavioral amplification contribute to symptom chronicity. The aims of evaluation in patients with POTS are to exclude cardiac causes of inappropriate tachycardia; elucidate, if possible, the most likely pathophysiologic basis of postural intolerance; assess for the presence of treatable autonomic neuropathies; exclude endocrine causes of a hyperadrenergic state; evaluate for cardiovascular deconditioning; and determine the contribution of emotional and behavioral factors to the patient's symptoms. Management of POTS includes avoidance of precipitating factors, volume expansion, physical countermaneuvers, exercise training, pharmacotherapy (fludrocortisone, midodrine, β-blockers, and/or pyridostigmine), and behavioral-cognitive therapy. A literature search of PubMed for articles published from January 1, 1990, to June 15, 2012, was performed using the following terms (or combination of terms): POTS; postural tachycardia syndrome, orthostatic; orthostatic; syncope; sympathetic; baroreceptors; vestibulosympathetic; hypovolemia; visceral pain; chronic fatigue; deconditioning; headache; Chiari malformation; Ehlers-Danlos; emotion; amygdala; insula; anterior cingulate; periaqueductal gray; fludrocortisone; midodrine; propranolol; β-adrenergic; and pyridostigmine. Studies were limited to those published in English. Other articles were identified from bibliographies of the retrieved articles.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mayocp.2012.08.013

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • More common than genetic NET deficiency is NET blockade from pharmacological agents, such as NE reuptake inhibitors, tricyclic antidepressants, and other sympathomimetic drugs.

    “More common than genetic NET deficiency is NET blockade from pharmacological agents, such as NE reuptake inhibitors (e.g., bupropion), tricyclic antidepressants (e.g., nortriptyline), and other sympathomimetic drugs (e.g., methylphenidate) (15).”

    From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [15]

    The ARTICLE HIGHLIGHTS passage says that increased norepinephrine levels more commonly reflect pharmacological NET blockade than the genetic NET deficiency described in a case. It names tricyclic antidepressants, selective NET inhibitors, and amphetamine-like drugs including methylphenidate, but does not name bupropion or nortriptyline as the citing sentence does. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Behavioral and cognitive therapy has been used to obtain long-term control of symptoms, particularly when anxiety, hypervigilance, or catastrophizing behaviors are present.

    “Behavioral and cognitive therapy has been used to obtain long-term control of symptoms, particularly when anxiety, hypervigilance, or catastrophizing behaviors are present (15).”

    From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [15]

    In “Why Are Some Patients With POTS So Difficult to Treat?” (page not supplied), the paper identifies somatic hypervigilance as a factor in persistent symptoms and says behavioral-cognitive approaches are more likely than pharmacotherapy to improve quality of life. It does not report that therapy has been used to achieve long-term symptom control or specifically identify catastrophizing behaviors. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Mechanisms described in POTS include autonomic denervation, hypovolemia, hyperadrenergic stimulation, deconditioning, and hypervigilance.

    “A number of mechanisms have been described in patients with POTS,18 including autonomic denervation, hypovolemia, hyperadrenergic stimulation, deconditioning, and hypervigilance”
  • The pathophysiological mechanisms underlying POTS are thought to be heterogeneous.

    “The pathophysiological mechanisms underlying POTS are thought to be heterogeneous (15).”

    From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [15]

  • Midodrine can cause urinary retention.

    “Improvement in symptoms and orthostatic tachycardia can be associated with scalp tingling and goosebumps [58], and midodrine can cause urinary retention [67].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [54]54. Mathys J, Beiser I, Maurer G, Humm AM. Orthostatic head- ache with tachycardia [in German]. Praxis (Bern 1994). 2011; 100(10):613-616.
  2. [74]74. Holstege G, Bandler R, Saper CB. The emotional motor sys- tem. Prog Brain Res. 1996;107:3-6.
  3. [85]85. Wieling W, van Lieshout JJ, van Leeuwen AM. Physical ma- noeuvres that reduce postural hypotension in autonomic fail- ure. Clin Auton Res. 1993;3(1):57-65.

Cited by

Sorted by citations

Authors
Benarroch, E. E.
Affiliations
Mayo Clinic (US)
Corresponding author
Benarroch, Eduardo E.
Venue
Mayo Clinic Proceedings
Publisher
Elsevier BV
Published
2012-12
Volume
87
Issue
12
Pages
1214-1225
ISSN
0025-6196 (ISSN-L)
OpenAlex
W2030172951
Cited by
370
References
98
Citations by year
2026: 19 · 2025: 22 · 2024: 29 · 2023: 28 · 2022: 32 · 2021: 35 · 2020: 36 · 2019: 26 · 2018: 37 · 2017: 29 · 2016: 26 · 2015: 23 · 2014: 23 · 2013: 5
FWCI
3.16
Type
journal article
Language
en
Open access
Locations
  • Mayo Clinic Proceedings (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Keywords
postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia, orthostatic intolerance, autonomic dysfunction, sympathoexcitation, vasoconstriction, hypovolemia, cardiovascular deconditioning, chronic fatigue, chronic dizziness, fibromyalgia, sleep disorders, anxiety and depression, fludrocortisone, midodrine, propranolol, pyridostigmine, exercise training, cognitive behavioral therapy, differential diagnosis, pathophysiology
MeSH terms
Drinking, Ehlers-Danlos Syndrome, Fibromyalgia, Gastrointestinal Motility, Headache, Humans, Sleep Initiation and Maintenance Disorders, Norepinephrine, Oxygen Consumption, Patient Education as Topic, Sodium, Dietary, Stroke Volume, Sympathetic Nervous System, Water, Exercise, Fatigue Syndrome, Chronic, Hypovolemia, Stockings, Compression, Postural Orthostatic Tachycardia Syndrome, Visceral Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review